PACS Group's Quality-First Model Fuels Record Growth and Market Dominance

SALT LAKE CITY, UT – February 26, 2026 – PACS Group, Inc. (NYSE: PACS) has cemented its position as a formidable leader in the post-acute healthcare sector, announcing record-breaking financial results for 2025 that significantly outpaced industry averages and underscored the success of its quality-centric growth strategy. The company reported a staggering 29.3% increase in annual revenue to $5.29 billion, alongside robust profitability and an optimistic forecast for 2026, sending its stock up 6% in after-hours trading.

The impressive performance highlights PACS Group's ability to thrive amidst a challenging healthcare environment, leveraging a disciplined expansion strategy and an operational model that directly links superior patient care to financial success. With high occupancy rates and top-tier quality ratings, the Salt Lake City-based company is not just growing; it's setting a new benchmark for performance in post-acute care.

A Financial Powerhouse in Post-Acute Care

PACS Group's fiscal year 2025 results paint a picture of remarkable financial health and operational leverage. The 29.3% surge in revenue from $4.09 billion in the prior year to $5.29 billion was driven by both strategic acquisitions and strong organic performance. More impressively, the company’s profitability soared, with net income reaching $191.5 million. Adjusted EBITDA, a key metric of operating performance, jumped by an astonishing 81% to $505.0 million for the full year, indicating significant margin expansion and efficiency gains.

This financial strength is built on a solid foundation. The company ended the year with $197.0 million in cash and cash equivalents and a remarkably low net leverage ratio of just 0.3x. This conservative capital structure provides substantial flexibility and firepower for its continued acquisition-focused growth strategy.

Looking ahead, the company provided confident guidance for 2026, projecting revenue to climb to a range of $5.65 billion to $5.75 billion and Adjusted EBITDA to reach between $555 million and $575 million. This forecast suggests management anticipates not just continued top-line growth but also further improvements in profitability.

“We’re pleased with our overall 2025 results, which reflect our commitment to exceptional patient care, superb quality, consistent operational excellence, and forward-looking strategic growth,” said Jason Murray, PACS’s Chief Executive Officer, in the company's press release.

The Quality-Driven Growth Engine

At the heart of PACS Group’s success is a core belief that clinical excellence is the primary driver of business performance. The company's results offer compelling evidence for this philosophy. In 2025, an impressive 73.4% of its skilled nursing portfolio—a total of 207 facilities—achieved a 4 or 5-star rating from the Centers for Medicare & Medicaid Services (CMS) on its Quality Measures. This includes 127 facilities with a coveted 5-star rating.

This performance stands in stark contrast to the industry, where the average rating hovers around 3.5 stars. PACS Group’s mature facilities, those operated for over three years, are even more distinguished, boasting an average rating of 4.4 stars. These high ratings are not merely for show; they are a financial lifeline in the skilled nursing industry, directly influencing hospital referrals and preference from lucrative Medicare Advantage plans.

The tangible outcome of this quality focus is seen in the company's occupancy rates. While the national industry average for skilled nursing facilities struggled to reach 79% in 2025, PACS Group’s mature facilities maintained a near-full occupancy rate of 94.9%. This ability to attract and retain patients provides a stable and predictable revenue stream, insulating the company from some of the volatility that plagues its competitors.

As Murray noted, quality care is a "key driver of our 29.3% revenue growth in 2025." This synergy between high-quality patient outcomes and robust financial returns forms the central pillar of the PACS Group story.

Disciplined Expansion and Operational Mastery

PACS Group’s rapid growth has been fueled by a disciplined yet aggressive acquisition strategy. In 2025 alone, the company added 8 operating facilities, incorporating 655 skilled nursing beds and 271 assisted living units. The pace has not slowed, with the company closing on 11 facilities in Tennessee in December and adding three more facilities in Alaska and Idaho in January 2026, bringing its total portfolio to 323 operated facilities across 17 states.

The company's success, however, lies not just in acquiring facilities but in effectively integrating them. This is achieved through its "locally-led, centrally-supported" operating model. This framework empowers local facility administrators to make day-to-day clinical and operational decisions while providing them with the robust backing of a corporate infrastructure that handles compliance, reporting, and resource management.

The effectiveness of this integration playbook is evident in the data. Facilities categorized as 'New' (operated for less than 18 months) typically start with an occupancy of 81.1% and an average daily revenue of $436. As they are integrated and mature within the PACS system, they transform. 'Mature' facilities, by contrast, achieve the 94.9% occupancy rate and generate a significantly higher average daily revenue of $526. This systematic improvement demonstrates the company's ability to unlock value and elevate performance across its expanding network.

“We also continue to execute on our strategic and disciplined growth strategy,” stated Mark Hancock, PACS’s Interim Chief Financial Officer, highlighting recent acquisitions and divestitures that have streamlined the portfolio. “With our locally-led, centrally-supported operating model and experience integrating larger acquisitions, we expect the transitions will be seamless.”

Navigating a Challenging Healthcare Landscape

PACS Group’s achievements are all the more notable given the persistent headwinds facing the post-acute care industry. Widespread labor shortages, rising operating costs, and complex reimbursement and regulatory environments have created significant pressure for providers. Many operators have been forced to limit admissions due to staffing constraints, while others struggle with tightening margins.

PACS Group appears to have built a resilient model to weather these storms. Its focus on quality makes it an employer of choice in local markets, and its high occupancy rates ensure efficient use of its skilled workforce. The company’s strong financial position and access to capital allow it to continue investing in its facilities, technology, and people at a time when many competitors are forced to cut back.

The company has also successfully navigated its own internal challenges, regaining full compliance with SEC filing requirements in late 2025 after an internal audit and federal investigation into past billing practices. With those issues addressed, management has signaled a clear focus on future execution.

“Our performance validates our core strengths and our capacity and ability to adapt to market conditions, regulatory changes, and the ongoing evolution of the post-acute care industry,” Murray concluded in his statement. As PACS Group moves into 2026, its proven ability to pair operational discipline with a deep commitment to quality care positions it to continue its impressive trajectory of growth and leadership.